Welcome to our dedicated page for Exzeo Group SEC filings (Ticker: XZO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Exzeo Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Exzeo Group's regulatory disclosures and financial reporting.
Exzeo Group, Inc. Chief Executive Officer Paresh Patel bought 2,000 shares of common stock in an open-market purchase at $13.89 per share. After this trade, he directly holds 1,590,013 common shares. He also holds stock options covering 5,000,000 shares at an exercise price of $23.00 per share, expiring on October 1, 2031, which vest over time according to a set schedule.
Exzeo Group, Inc. Chief Executive Officer and director Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $14.52 per share. Following this transaction, he directly holds 1,588,013 shares of common stock.
The filing also notes a stock option granting the right to buy 5,000,000 shares of common stock at an exercise price of $23.00 per share, expiring on October 1, 2031. According to the footnote, this option was granted on October 1, 2021 and vests over time, with one fourth vesting on October 1, 2022 and additional portions vesting quarterly thereafter.
Exzeo Group, Inc. director and Chief Executive Officer Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $14.81 per share. Following this transaction, he directly owns 1,586,013 common shares. The filing also lists a stock option to buy 5,000,000 common shares at an exercise price of $23.00 per share, expiring on October 1, 2031. According to the disclosure, this option was granted on October 1, 2021 and vests over time, with one fourth vesting on October 1, 2022 and additional portions vesting on each January 1, April 1, July 1 and October 1 thereafter.
Exzeo Group, Inc. director James J. Macchiarola bought 4,000 shares of common stock in an open-market transaction at $15.12 per share. Following this purchase, he directly owns 140,000 Exzeo Group common shares, indicating a modest increase in his personal stake in the company.
Exzeo Group, Inc. director and Chief Executive Officer Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $14.99 per share. Following this transaction, he directly owns 1,584,013 common shares.
He also holds a stock option granted on October 1, 2021 to purchase 5,000,000 common shares at an exercise price of $23.00 per share, expiring on October 1, 2031. The option vested one-fourth on October 1, 2022 and one-sixteenth on each January 1, April 1, July 1, and October 1 thereafter.
Exzeo Group, Inc. Chief Executive Officer Paresh Patel reported a series of open-market purchases of the company’s common stock. On March 19, 20 and 23, 2026, he bought 2,000 shares on each day, totaling 6,000 shares, at prices between $14.93 and $15.50 per share.
After these transactions, Patel directly owns 1,582,013 shares of common stock. He also holds a stock option granted on October 1, 2021 to purchase 5,000,000 shares at an exercise price of $23.00 per share, expiring on October 1, 2031, which vests over time.
Exzeo Group, Inc. director and CEO Paresh Patel bought 4,000 shares of Common Stock in open-market transactions. He purchased 2,000 shares on March 17, 2026 at $15.68 per share and another 2,000 shares on March 18, 2026 at $16.30 per share.
Following these buys, he directly owns 1,576,013 Common shares. He also holds a stock option granted on October 1, 2021 to purchase 5,000,000 Common shares at an exercise price of $23.00 per share, expiring October 1, 2031, which vests over time according to a stated schedule.
Exzeo Group, Inc. director Robert A. Lopes Jr. reported an open-market purchase of 2,500 shares of common stock at $15.35 per share on March 9, 2026. Following this trade, he directly holds 127,335 common shares.
Exzeo Group, Inc. files its annual report describing a turnkey insurance technology and operations business built around its proprietary Exzeo Platform for P&C carriers. The platform supports quoting, underwriting, policy administration, claims management, analytics and financial reporting, typically billed as a variable fee based on premium volume.
Exzeo now focuses on technology and services after selling its TTIC insurance carrier subsidiary to HCI on July 1, 2024, with TTIC reported as discontinued operations. As of February 20, 2026, the company had 90,913,540 common shares outstanding and employed about 354 full-time staff, mainly in the U.S. with development in India.
The report highlights dependence on a small number of customers largely affiliated with majority owner HCI, geographic exposure to Florida and other coastal states, intense InsurTech competition, extensive regulation, cybersecurity and data-privacy obligations, and risks from natural catastrophes and climate-related events that can affect customers’ P&C businesses and demand for Exzeo’s services.
Exzeo Group, Inc. reported strong growth for the year ended December 31, 2025. Full-year revenue rose 62% to $216.98 million, while net income from continuing operations climbed to $82.75 million, up from $26.07 million. Basic and diluted earnings per share from continuing operations increased to $0.99 from $0.20.
Profitability improved sharply, with Adjusted EBITDA rising to $111.52 million and Adjusted EBITDA Margin expanding to 54.2% from 36.6%. Cash and cash equivalents grew to $305.37 million as of year-end 2025, supported by $100.30 million of cash from operating activities and Free Cash Flow of $97.45 million.